Abstract
Antisense oligonucleotides are powerful tools for the in vivo regulation of gene expression. We have characterized the intracellular distribution of fluorescently tagged phosphorothioate oligodeoxynucleotides (PS-ONs) at high resolution under conditions in which PS-ONs have the potential to display antisense activity. Under these conditions PS-ONs predominantly localized to the cell nucleus where they accumulated in 20–30 bright spherical foci designated phosphorothioate bodies (PS bodies), which were set against a diffuse nucleoplasmic population excluding nucleoli. PS bodies are nuclear structures that formed in cells after PS-ON delivery by transfection agents or microinjection but were observed irrespectively of antisense activity or sequence. Ultrastructurally, PS bodies corresponded to electron-dense structures of 150–300 nm diameter and resembled nuclear bodies that were found with lower frequency in cells lacking PS-ONs. The environment of a living cell was required for the de novo formation of PS bodies, which occurred within minutes after the introduction of PS-ONs. PS bodies were stable entities that underwent noticeable reorganization only during mitosis. Upon exit from mitosis, PS bodies were assembled de novo from diffuse PS-ON pools in the daughter nuclei. In situ fractionation demonstrated an association of PS-ONs with the nuclear matrix. Taken together, our data provide evidence for the formation of a nuclear body in cells after introduction of phosphorothioate oligodeoxynucleotides.
References
71
Referenced
66
10.1093/nar/24.20.4063
/ Nucleic Acids Res. by Abdul-Manan N. (1996)10.1016/0167-7799(96)10053-6
/ Trends Biotechnol. by Agrawal S. (1996)10.1016/0958-1669(95)80003-4
/ Curr. Opin. Biotechnol. by Agrawal S. (1995)10.1128/JVI.71.6.4599-4613.1997
/ J. Virol. by Ahn J.H. (1997)10.1073/pnas.90.5.1947
/ Proc. Natl. Acad. Sci. USA by Andrade L.E. (1993)10.1074/jbc.272.18.11994
/ J. Biol. Chem. by Baker B.F. (1997)10.1016/S0040-4020(01)88752-4
/ Tetrahedron by Beaucage S.L. (1992)10.1172/JCI117860
/ J. Clin. Invest. by Beltinger C. (1995){'key': 'B9', 'first-page': '1023', 'volume': '41', 'author': 'Bennett C.F.', 'year': '1992', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. by Bennett C.F. (1992)10.4049/jimmunol.152.7.3530
/ J. Immunol. by Bennett C.F. (1994){'key': 'B11', 'first-page': '988', 'volume': '280', 'author': 'Bennett C.F.', 'year': '1997', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. by Bennett C.F. (1997)10.1002/jcb.240470204
/ J. Cell. Biochem. by Berezney R. (1991)10.1242/jcs.1995.Supplement_19.16
/ J. Cell Sci. Suppl. by Bohmann K. (1995)10.1073/pnas.92.16.7297
/ Proc. Natl. Acad. Sci. USA by Boussif O. (1995)10.1016/0014-4827(92)90068-J
/ Exp. Cell Res. by Brasch K. (1992)10.1016/S0021-9258(18)47090-1
/ J. Biol. Chem. by Brown D.A. (1994)10.1002/j.1460-2075.1994.tb06369.x
/ EMBO J. by Burd C.G. (1994)10.1111/j.1768-322X.1984.tb00220.x
/ Biol. Cell by Chaly N. (1983)10.1016/S0021-9258(18)55250-9
/ J. Biol. Chem. by Chiang M.Y. (1991){'key': 'B20', 'first-page': '1091', 'volume': '2', 'author': 'Chin D.J.', 'year': '1990', 'journal-title': 'New Biol'}
/ New Biol by Chin D.J. (1990)10.1016/S0021-9258(18)53363-9
/ J. Biol. Chem. by Clarenc J.P. (1993)10.1126/science.272.5263.877
/ Science by Coats S. (1996)10.1074/jbc.271.48.30398
/ J. Biol. Chem. by Condon T.P. (1996)10.1002/(SICI)1098-1128(199607)16:4<319::AID-MED2>3.0.CO;2-#
/ Med. Res. Rev. by Crooke S.T. (1996)10.1016/S1054-3589(08)60136-2
/ Adv. Pharmacol. by Crooke S.T. (1997)10.1146/annurev.pa.36.040196.000543
/ Annu. Rev. Pharmacol. Toxicol. by Crooke S.T. (1996)10.1073/pnas.91.24.11762
/ Proc. Natl. Acad. Sci. USA by Dean N.M. (1994)10.1042/bst0240623
/ Biochem. Soc. Trans. by Dean N.M. (1996){'key': 'B29', 'first-page': '3499', 'volume': '56', 'author': 'Dean N.', 'year': '1996', 'journal-title': 'Cancer Res.'}
/ Cancer Res. by Dean N. (1996)10.1083/jcb.102.5.1654
/ J. Cell Biol. by Fey E.G. (1986)10.1093/nar/21.16.3857
/ Nucleic Acids Res. by Fisher T.L. (1993)10.1093/nar/24.15.2936
/ Nucleic Acids Res. by Flanagan W.M. (1996)10.1038/343437a0
/ Nature by Fu X.-D. (1990)10.1089/ard.1995.5.23
/ Antisense Res. Dev. by Giles R.V. (1995)10.1006/excr.1996.0124
/ Exp. Cell Res. by Haaf T. (1996)10.4049/jimmunol.143.8.2560
/ J. Immunol. by Habets W.J. (1989)10.1016/S0074-7696(08)61587-9
/ Int. Rev. Cytol. by Hougaard D.M. (1992)10.1083/jcb.126.4.877
/ J. Cell Biol. by Huang S. (1994)10.1083/jcb.133.4.719
/ J. Cell Biol. by Huang S. (1996)10.1083/jcb.134.4.815
/ J. Cell Biol. by Ishov A.M. (1996)10.1002/j.1460-2075.1994.tb06356.x
/ EMBO J. by Koken M.H. (1994)10.1093/nar/16.20.9415
/ Nucleic Acids Res. by Krainer A.R. (1988)10.1073/pnas.88.7.2702
/ Proc. Natl. Acad. Sci. USA by Leonetti J.P. (1991)10.1182/blood.V87.4.1326.bloodjournal8741326
/ Blood by Luger S.M. (1996)10.1002/(SICI)1097-4644(199704)65:1<42::AID-JCB5>3.0.CO;2-Z
/ J. Cell. Biochem. by Mattern K.A. (1997)10.1038/nm0696-668
/ Nat. Med. by Monia B.P. (1996)10.1073/pnas.77.3.1627
/ Proc. Natl. Acad. Sci. USA by Moroi Y. (1980)10.1111/1523-1747.ep12396876
/ J. Invest. Dermatol. by Nestle F.O. (1994)10.1038/nm0996-998
/ Nat. Med. by Neurath M.F. (1996)10.1083/jcb.116.5.1095
/ J. Cell Biol. by O’Keefe R.T. (1992)10.1091/mbc.6.3.345
10.1002/j.1460-2075.1993.tb05767.x
/ EMBO J. by Offensperger W.B. (1993)10.1038/355730a0
/ Nature by Piñol-Roma S. (1992)10.1007/s004180050115
/ Histochem. Cell Biol. by Roch A.M. (1997)10.1002/bies.950171210
/ Bioessays by Sharma H.W. (1995)10.1089/oli.1.1997.7.291
/ Antisense Nucleic Acid Drug Dev. by Shoeman R.L. (1997)10.1002/j.1460-2075.1988.tb02830.x
/ EMBO J. by Shuttleworth J. (1988)10.1146/annurev.cb.09.110193.001405
/ Annu. Rev. Cell Biol. by Spector D.L. (1993)10.1002/j.1460-2075.1991.tb04911.x
/ EMBO J. by Spector D.L. (1991)10.1091/mbc.3.5.555
10.1016/0167-7799(96)20006-X
/ Trends Biotechnol. by Stein C.A. (1996)10.4049/jimmunol.153.11.5336
/ J. Immunol. by Stepkowski S.M. (1994)10.1242/jcs.101.4.773
/ J. Cell Sci. by Stuurman N. (1992)10.1089/ard.1995.5.193
/ Antisense Res. Dev. by Tarrason G. (1995){'key': 'B65', 'first-page': '1590', 'volume': '55', 'author': 'Terris B.', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. by Terris B. (1995)10.1093/nar/20.21.5691
/ Nucleic Acids Res. by Thierry A.R. (1992)10.1016/S1357-4310(96)10053-8
/ Mol. Med. Today by Wagner R.W. (1997)10.1038/nbt0796-840
/ Nat. Biotechnol. by Wagner R.W. (1996)10.1126/science.7684856
/ Science by Wagner R.W. (1993)10.1016/S0140-6736(96)11103-X
/ Lancet by Webb A. (1997)10.1016/0014-5793(95)00517-D
/ FEBS Lett. by Weidner D.A. (1995)
Dates
Type | When |
---|---|
Created | 12 years, 1 month ago (July 2, 2013, 7:13 p.m.) |
Deposited | 2 years, 1 month ago (July 2, 2023, 5:05 p.m.) |
Indexed | 2 weeks, 6 days ago (Aug. 3, 2025, 7:06 p.m.) |
Issued | 27 years, 3 months ago (May 1, 1998) |
Published | 27 years, 3 months ago (May 1, 1998) |
Published Print | 27 years, 3 months ago (May 1, 1998) |
@article{Lorenz_1998, title={Phosphorothioate Antisense Oligonucleotides Induce the Formation of Nuclear Bodies}, volume={9}, ISSN={1939-4586}, url={http://dx.doi.org/10.1091/mbc.9.5.1007}, DOI={10.1091/mbc.9.5.1007}, number={5}, journal={Molecular Biology of the Cell}, publisher={American Society for Cell Biology (ASCB)}, author={Lorenz, Peter and Baker, Brenda F. and Bennett, C. Frank and Spector, David L.}, year={1998}, month=may, pages={1007–1023} }